An essential role for programmed death-1 in the control of autoimmunity: implications for the future of hematopoietic stem cell transplantation

Author： Thangavelu Govindarajan   Anderson Colin C  

Publisher： Future Medicine

ISSN： 1479-6694

Source： Future Oncology, Vol.7, Iss.8, 2011-08, pp. : 929-932

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hematopoietic stem cell transplantation: more than just hematopoietic?

By Spyridonidis Alexandros   Mertelsmann Roland   Finke Jürgen  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 3, 2004-03 ,pp. : 127-134

Springer Publishing Company

Access to resources Recommend Favorite

Predictive Efficacy Biomarkers of Programmed Cell Death 1/Programmed Cell Death 1 Ligand Blockade Therapy

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 11, Iss. 2, 2016-04 ,pp. : 141-151

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in treatment of peripheral T-cell lymphoma with hematopoietic stem cell transplantation

By Zhou Lilan   He Mingsheng  

The Chinese-German Journal of Clinical Oncology, Vol. 10, Iss. 5, 2011-05 ,pp. : 293-296

Springer Publishing Company

Access to resources Recommend Favorite

Recent Progress in the Field of Hematopoietic Stem Cell Transplantation for Leukemia

By Kobayashi Takeshi   Akiyama Hideki  

Japanese Journal of Cancer and Chemotherapy, Vol. 36, Iss. 3, 2009-03 ,pp. : 351-356

Sunmedia

Access to resources Recommend Favorite

Therapeutic effects of autologous hematopoietic stem cell transplantation in multiple myeloma patients

By                    

Experimental and Therapeutic Medicine, Vol. 6, Iss. 4, 2013-01 ,pp. : 977-982

Spandidos Publications

Access to resources Recommend Favorite